These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hair transplants for male pattern baldness--special clinical and mathematical considerations. Ginsberg JE Cutis; 1970 Oct; 6(10):1113-20. PubMed ID: 5212474 [No Abstract] [Full Text] [Related]
7. New investigational drugs for androgenetic alopecia. Valente Duarte de Sousa IC; Tosti A Expert Opin Investig Drugs; 2013 May; 22(5):573-89. PubMed ID: 23550739 [TBL] [Abstract][Full Text] [Related]
8. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies. Gassmueller J; Hoffmann R; Webster A Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309 [TBL] [Abstract][Full Text] [Related]
15. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Rathnayake D; Sinclair R Dermatol Clin; 2010 Jul; 28(3):611-8. PubMed ID: 20510769 [TBL] [Abstract][Full Text] [Related]
16. Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment. Atanaskova Mesinkovska N; Bergfeld WF Dermatol Clin; 2013 Jan; 31(1):119-27. PubMed ID: 23159181 [TBL] [Abstract][Full Text] [Related]
17. Evaluation and treatment of male and female pattern hair loss. Olsen EA; Messenger AG; Shapiro J; Bergfeld WF; Hordinsky MK; Roberts JL; Stough D; Washenik K; Whiting DA J Am Acad Dermatol; 2005 Feb; 52(2):301-11. PubMed ID: 15692478 [No Abstract] [Full Text] [Related]
18. Topical antiandrogens in the treatment of male-pattern baldness. Rittmaster RS Clin Dermatol; 1988; 6(4):122-8. PubMed ID: 3063366 [TBL] [Abstract][Full Text] [Related]